Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.

The Canadian journal of urology

Volumn 9, Issue 5, 2002, Pages 1625-1633

  Segal, Roanne ^a   Winquist, Eric ^a   Lukka, Himu ^a   Chin, Joseph L ^a   Brundage, Michael ^a   Markman, B R ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLADDER TUMOR; CANCER INVASION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYSTECTOMY; EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; CYSTECTOMY; DOXORUBICIN; EPIRUBICIN; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHATIC METASTASIS; METHOTREXATE; NEOPLASM INVASIVENESS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0036781265     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)